February 18, 2022
At Ending Age-Related Diseases 2021, Greg Fahy discussed TRIIM-X, the ongoing continuation of his original TRIIM trial, along with some surprising findings from it. Script I'm just going to try to update everybody on the TRIIM-X clinical trial. I will explain where that came from, just to make sure everybody has the same background in...
November 05, 2019
Dr. Greg Fahy, Chief Scientific Officer of Intervene Immune, has recently appeared on The Damage Report, a news and current events show that is part of The Young Turks (TYT) network. Hosts John Iadarola and Brooke Thomas talked with Dr. Fahy about the recent positive results of his company's human clinical trial for thymus rejuvenation....
September 06, 2019
A small clinical trial, which was conducted by a team of researchers led by Dr. Greg Fahy, has shown for the first time in humans that reversing biological age may be possible. The results of TRIIM are in The researchers spent a year running the Thymus Regeneration, Immunorestoration, and Insulin Mitigation (TRIIM) trial, which included...
March 22, 2019
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech. We will be bringing you the latest aging research, investment, and business knowledge from some of the top...
October 04, 2017
The thymus gland is located at the top of the breastbone and is where the majority of T cells are produced by the immune system. One can think of the thymus as being like an army camp where new soldiers are trained and given their weapons to fight invading forces; in this case, the T...